| MolName | (2S,3R,4S,5S,6R)-2-[[(1S,2S,4S,5S,6R,10S)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.02,4]decan-10-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| MolecularFormula | C15H24O10 |
| Smiles | OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1O[C@@H]1OCC[C@@H]2[C@H]1[C@@]1(CO)O[C@H]1[C@H]2O |
| InChI | InChI=1S/C15H24O10/c16-3-6-9(19)10(20)11(21)14(23-6)24-13-7-5(1-2-22-13)8(18)12-15(7,4-17)25-12/h5-14,16-21H,1-4H2/t5-,6+,7+,8+,9-,10+,11+,12-,13-,14-,15+/m0/s1 |
| InChIK | NYCXYIWXBJWWIL-CDEJVSDRSA-N |
| TotalMolweight | 364.346 |
| Molweight | 364.346 |
| MonoisotopicMass | 364.13695 |
| CLogP | -3.3428 |
| CLogS | -0.337 |
| H Acceptors | 10 |
| H Donors | 6 |
| TotalSurfaceArea | 235.7 |
| Relative PSA | 0.53564 |
| PolarSurfaceArea | 161.6 |
| Druglikeness | -4.3182 |
| Mutagenic | high |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | oxiran/aziridine |
| Shape Index | 0.44 |
| Fragments | 1 |
| Non HAtoms | 25 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| StereoCenters | 11 |
| Rotatable Bond | 4 |
| Rings Closures | 4 |
| Small Rings | 5 |
| Sp3Atoms | 25 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - (2S,3R,4S,5S,6R)-2-[[(1S,2S,4S,5S,6R,10S)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.02,4]decan-10-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | 2 - (2S,3R,4S,5S,6R)-2-[[(1S,2S,4S,5S,6R,10S)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.02,4]decan-10-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol